A study indicates that high intrahepatic or circulating PCSK9 levels increase liver lipid storage and secretion, thus contributing to the pathogenesis of NAFLD [136]. The gene discussed is PCSK9; the disease is metabolic dysfunction-associated steatotic liver disease.